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Abstract: 
 Type I Diabetes (T1D) is a chronic autoimmune mediated form of insulin 
resistance that has lasting socioeconomic effects from childhood through old age that 
may impact labor force participation. Examining this relationship will enhance our 
understanding of life-long chronic illness beyond individual medical/financial impact by 
establishing broader socioeconomic implications. This study utilized data from the 2008-
2015 data set of the Medical Expenditure Panel Survey (MEPS), to explore the effects of 
T1D on labor force participation. It was hypothesized that having T1D would decrease 
both employability and contribution to the labor force. Utilizing methods of propensity 
score matching and entropy balancing, the hypothesis was shown to be correct, with T1D 
having an overall negative effect on labor force participation in regards to employability 
and number of sick days taken. This study highlights the need for further insight into the 
individual factors of those with T1D that lend to a decreased participation in the labor 
force.  
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I. Introduction  
Type I diabetes mellitus (T1D) is a chronic autoimmune mediated form of insulin 
deficiency defined by the progressive self-destruction of pancreatic insulin producing -
cells (Cnop et al., 2005; Saberzadeh-Ardestani et al., 2018; Williams & Farrar, 1986). 
With no known cause and no curative treatment, those affected with the illness require a 
constant supply of an exogenous insulin analogue throughout their lifetime in order to 
maintain normal levels of blood glucose which are otherwise lethal (Katsarou et al., 
2017). Despite tediously calculated insulin dosing with an exogenous insulin analogue 
based on method of administration, weight, food intake, exercise and metabolic basal 
rate, maintaining constant levels of normoglycemia is extremely difficult. As a result, 
most individuals affected with this immune mediated illness end up developing life-
threatening diabetic related complications including cardiovascular (heart disease, stroke, 
cardiomyopathy) and microvascular (retinopathy, neuropathy, kidney disease) (López-
Bastida et al., 2017).  
Type II diabetes (T2D), on the other hand, is an insulin independent metabolic 
mediated form of diabetes which is usually developed in older adulthood due to insulin 
resistance. The typical treatment regimen for T2D is significantly less demanding and 
usually consists of an insulin resistance lowering drug, with more severe cases requiring a 
daily dose of an insulin analogue. Additionally, the rate of hospitalization and life-
threatening episodes of diabetic related events such as hypoglycemia and diabetic 
ketoacidosis is disproportionately higher for T1D’s. With obesity at an all-time high in 
the United States(Ortega & Lavie, 2018), the prevalence of Type II diabetes, despite its 
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prevention with healthy diet and exercise, far exceeds that of Type I diabetes(National 
Institute of Diabetes and Digestive Kidney Diseases, 2017).. As a result, the vast majority 
of socioeconomic studies looking at the impact of diabetes on productivity and overall 
economic well-being have been mainly conducted on either “diabetics” as a whole or 
focusing solely on those with T2D. One major reason as to why this lack of distinction is 
problematic lies in the duration of each disease. T1D is a life-long chronic illness that 
begins during childhood, therefore productivity of these individuals is impacted over 
decades and spans into adulthood.  
A lack of metabolic control and diabetic complications in children with T1D has 
been found to negatively affect school attendance and performance (Nielsen, Ovesen, 
Mortensen, Lau, & Joensen, 2016a). Additionally, parents reportedly have to take more 
time off of work and spend extra money on resources caring for their child (i.e. 
monitoring systems, home education, private childcare, medication, etc.)(Tao et al., 
2010). This lends itself to downstream consequences resulting in a lack of success in the 
labor market since “school-leavers with few or no qualifications are at a greater risk of 
unemployment throughout adulthood.” Contribution to the labor market and society 
would likely have been established in those with T1D, as opposed to those with T2D who 
develop the illness by the time they are already established members of the labor market.  
According the National Institute of Diabetes and Digestive and Kidney Diseases 
(NIDDK), an estimated 30.3 million American are affected with diabetes, with only 1.5 
million of those individuals having T1D. Accordingly, T1D only accounts for 
approximately 5% of all individuals affected with diabetes in the Unites States (Roberts 
& Smith, 2018). Despite the significantly lower population of affected individuals, the 
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average annual cost of illness (COI) per case of T1D is reportedly $14,856, in 
comparison to $9,677 for T2D (Dall et al., 2010). Currently, epidemiological and 
socioeconomic studies done in the United States rarely distinguish between these two 
pathophsyiologically different forms of diabetes. Additionally, this life-long illness, 
typically diagnosed during early adolescence, is often left ignored when studying the 
impact on labor force participation in society.  
Current research and data on the effects of T1D, specifically, on education, 
occupational status and overall contribution to society is extremely limited. Based on a 
thorough literature search, the majority of published studies explore very limited data 
from non-US countries, with most including all forms of diabetes in their analysis (Brod, 
Christensen, Thomsen, & Bushnell, 2011; Federation, n.d.; Geelhoed-Duijvestijn et al., 
2013; López-Bastida et al., 2017; Nielsen, Ovesen, Mortensen, Lau, & Joensen, 2016b; 
Steen Carlsson et al., 2010). The aim of this study is to demonstrate the effects of T1D on 
United States labor force participation and productivity (measured as income in this 
paper).  
II. Literature Review  
As previously mentioned, prior research focusing on the impact of T1D on the 
labor market is mainly limited to countries outside of the United States. The majority of 
literature utilizes data from either Sweden and Finland, two countries with the highest 
incidence of T1D.  According to the 2011 survey reported by the International Diabetes 
Federation’s Diabetes Atlas, both Finland and Switzerland have an incidence of 57.6 and 
43.1, respectively, per 100,000 children ages 0 to 14. This is in comparison to 23.7 per 
100,000 cases in the United States. Although this data is international, the correlation 
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between disease state and labor force contribution, as well as economic modeling used to 
analyze this data can be extended to the methods considered for this study.   
In a study published by Persson et. al in 2018, the effect of T1D on labor market 
outcomes in Sweden is analyzed population utilizing data from the Swedish Childhood 
Diabetes Register (SCDR) of those born between 1962 and 1979(Persson, Dahlquist, 
Gerdtham, & Steen Carlsson, 2018). The SCDR is a database of children diagnosed with 
T1D under the age of 15, used to study long term consequences of T1D and its 
complications. The database is linked to a number of Swedish governmental databases 
with data matched to each person via a Swedish personal identification number. For 
example, data was linked from the SCDR to the Longitudinal Integration Database for 
Health Insurance and Labor Market Studies (LISA), as well as the National Board of 
Health and Welfare. Correlation between T1D on employment and earning were assed 
with the use of four mediating variables—adult health, education, occupation and family 
formation while controlling for both demographic and socioeconomic background.  
The Sobel-Goodman mediation test was utilized to assess the effects of each 
variable on employment and earning of T1D vs healthy controls. Statistical analysis 
showed that childhood-onset T1D negatively impacted employment with an odd’s ratio 
of 0.68 (95% CI) as well as earnings with an odds ratio of 0.76 (95% CI). Absenteeism 
from work was reported to contribute to over 50% of negative effects on earning potential 
of individuals with T1D. Additionally, it was found that occupation was selected based 
on work place flexibility with sick time for diabetes care related events. This lends itself 
to the importance of my study, exploring the effects of T1D on labor participation.      
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 An additional case-controlled study conducted in1989 by Thomas J. Songer, et al, 
explored the consequences of T1D on employment outlook in the United States (Songer 
et al., 1989). Using a cohort of 158 T1D’s and 158 healthy control siblings, the 
“employability” of each T1D individual relative to their paired healthy control was 
assessed. Individuals with T1D reported a higher rate of job refusal (56% vs. 42%, p = 
.02, n = 151 pairs, odds ratio 1.75, 95% Cl 1.07,2.92) as well as a lower rate of full time 
employment, (67.3% vs. 84.6%; P < .01). Decrease in full time employment was 
attributed to work disability (due to diabetic related complications) which was reportedly 
7 times greater relative to the healthy patient-matched control. The study also suggested 
hiring discrimination towards those with T1D due to a perceived inability to maintain 
good job attendance record.   
Additional studies focusing on labor market experience of individuals with T1D 
in Sweden and Norway, found that those with T1D were less likely to be employed in 
comparison to non-T1D individuals as well as the general population. Job refusal and 
discrimination studies of those with diabetes (undistinguished) were found to have an 
increased absenteeism (Milton, Holland, & Whitehead, 2006). Such studies are lacking in 
the United States. Studies that have been found only reference the diabetic population as 
a whole, without distinction for T1D. Therefore, the results may not truly represent the 
employment experience of the T1D community. 
In the study published by Betty Tao et. Al in 2010, the cost of type 1 diabetes in 
the U.S. was estimated by using a nationally representative data set which includes data 
from National Health and Nutrition Examination Survey (NHANES) matched with data 
from the MEPS, where they identified T1D patients by applying the “clinically-derived 
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definition”; using age of onset, body mass index and usage of insulin therapy. Most other 
studies defined diabetes by asking whether a participant has ever been told by a physician 
that they have diabetes. They noticed an exception with NHANES which goes further by 
administering a C-peptide test for T1D. Tao et. al noticed that this method of 
identification led to a very small population of T1D patients and this is why they used the 
clinically derived method above by refined their population by eliminating children under 
18 diagnosed with diabetes who are also considered obese with this they had accounted 
for overestimation or underestimation of their population. To ensure that T1D was the 
only differing variable for their population they adopted a form of matching called 
propensity score matching, which is basically a way of creating a control group where 
there is only one thing separating the two groups (in this case the presence of T1D). To 
do this they included a slew of relevant covariates to determine the nondiabetic diabetic-
type sample. They chose variables that were independent of whether or not the individual 
has T1D, after conditioning for all the matching covariates to ensure that having T1D is 
the only difference between a T1D patient and their matched counterpart that would 
affect the outcome.  
The authors used a logit specification to achieve the T1D propensity score and 
applied one to one matching with replacement, to test the sensitivity of their matching 
they used kernel density matching which will use all the nondiabetics for comparison but 
weighed their importance by the propensity score. They didn’t find any difference in their 
results from their main analysis, they then calculated their standard error by 
bootstrapping with 500 iterations and reported a 95 percent confidence interval for all 
their results. Their suitable covariates for matching were age, female, Metropolitan 
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statistical area (MSA), Nonwhite, Region, Year, Birth weight, Height, U.S. Citizen, In 
U.S. < 15 years, Eczema, Arthritis, Cancer, Mom finished HS and Dad finished HS. We 
would be adopting their matching method by using the same covariates that exist in our 
dataset and also generating a propensity score match with a logistical regression, we 
would also be using the clinically derived definition for T1D they have used in their 
study as this is the only way we can define T1D in our dataset, our study would also 
differ from theirs as they were trying to estimate the cost of the disease while we are 
trying to see the effect on the disease on wages and labor force participation. 
Finally, in a 2013 study by Travis minor, he tried to investigate the effect of type 
1 and type 2 diabetes duration on employment and wages(Travis Minor, 2011). His 
dataset is from the National Longitudinal Survey of Youth from 1979 and from there he 
determines his employment variable as either employed or unemployed and his T1D 
variable is defined by if the participant was diagnosed with diabetes before the age of 20 
and if after T2D. He runs a logit regression to differentiate between participants being 
employed or not based on the various kinds of diabetes. He also runs a wage model to 
determine the participants logarithmic hourly wage based on the kinds of diabetes using 
the OLS method. His results showed that both the probability of employment and wages 
are negatively related to the number of years since the initial diagnosis of diabetes, he 
also showed that the effect of diabetes duration on the probability of employment shows 
to be nonlinear and peaked around the ages of 16 for females and 10 for males. He found 
a similar negative effect on wages is found in only diabetics that are male. He further 
stressed that failure to distinguish between the two types of diabetes may lead to 
counterintuitive results. We would be using similar definition for our employment 
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variable but we would be user newer data and specifically targeting type 1 diabetes in 
order to improve on his study. 
 This paper therefore serves a purpose of analyzing the effects of T1D on labor 
force participation using data selected from the Medical Expenditure Panel Survey using 
a number of criteria to distinguish those with T1D from those with T2D with a similar 
method of T1D definition and matching as Tao et. Al but using the same definition of 
employment and impressing on Travis Minor’s study by only focusing on T1D. 
IV. METHODOLOGY 
1. DATA 
In order to determine the effects of T1D on labor force participation, data from 
the 2008 – 2015 MEPS Full Year Consolidated files was used. The MEPS data set is 
derived from a large-scale survey of households and individuals living in the United 
States. Information collected includes demographic (i.e. age, sex, ethnicity, etc.), 
socioeconomic characteristics, medical records (i.e. health conditions, smoking status, 
medications, laboratory results, etc.), missed work days, healthcare use, costs and health 
insurance coverage.   
Survey participants were de-identified, and a randomized study ID was assigned, 
as designated by the “DUPERSID” variable. Each de-identified participant was followed 
for a duration of two years, with each participant asked to answer a slew of questions 
(with 3 rounds per year). The information is self-reported and heavily detailed. 2008 was 
chosen as the start date for data analysis since that was the year MEPS started recording 
age of onset for diabetes (DIABAGED). MEPS does not distinguish between T1D and 
T2D, therefore, by utilizing age of onset as well as BMI, I was able to determine if an 
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individual had T1D or T2D. Lastly, 2015 was the most recent consolidated survey date, 
hence why it was used as the end point for data collection.  
My T1D variable was created by using the MEPS variable “diabaged”; the 
inclusion criteria were limited to individuals diagnosed with “diabetes” prior to the age of 
25 with a BMI lower than 30 which is similar to the method adopted by Tao et. Al. 
Since I was focusing specifically on effects of T1D on labor force participation, 
an age guideline was used to define the workforce population. Therefore, I re-filtered the 
T1D population to people that fall between the ages of 25 – 50. Generally speaking, this 
would include individuals who are both post college and pre-retirement age. In the end, 
out of an initial study population of 52,213, my selection criteria yielded a total of 205 
T1D’s (0.39%). This seems to accurately reflect the incidence of T1D in the United 
States which is estimated to be about 0.3-0.6% of the population(Dall et al., 2009)..   
2. REGRESSIONS 
 I started with a simple Ordinary Least Squares (OLS) regression (without 
balancing) by regressing the dependent variables on the independent variables. 
Dependent variables included employed, log of sick days and log of wage. The 
independent variables included age, age squared, income, a nonwhite dummy variable, a 
set of region dummy variables, a set of education dummy variables, female, marital status 
and a set of year dummy variables. An OLS regression was decidedly the best baseline 
strategy since it represents a very straightforward way to model. 
To specifically identify the effects of T1D on employability, it was essential to 
match a T1D patient to a person without T1D. To find an exact match or as close to one 
as possible, I had to create a control group and a treatment group by using propensity 
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score matching to evaluate Treatment-effect (T-effect). Propensity score matching 
involves trying to match the control and treatment group as much as possible where the 
only difference between them can be attributed to T1D (Tao et al., 2010). This would 
allow me to account for differences observed between those with T1D and those without, 
such as having less education due to missing classes or less income from taking more 
sick days. Without balancing via propensity score matching, the treatment and control 
groups would be heterogeneous. This would also reduce the risk of imbalance that stems 
from the small population size associated with T1D. A similar method was employed by 
Tao et al who used the Rosenbaum and Rubin propensity score matching methods, 
including other covariates to ensure the matched control individuals were similar enough 
where the only difference was their T1D.  
 For my first propensity score matching I used a logit regression to estimate the 
propensity of having T1D. The following were used as independent variables; “age,” 
“age squared,” “nonwhite,” “region,” “cancer,” “arthritis,” “female,” “marital status,” 
“education” and “year.” Individuals without T1D who had a high propensity to have T1D 
were used as a control group. I used the “teffect” command in Stata, which allowed me to 
estimate the average treatment effect, or the “ATE” as well as the average treatment 
effect on the treated called the “ATET.” In this regression, the ATE would be the effects 
of having T1D on the average person, while the ATET would be the effect of having T1D 
on the people with T1D. The equation below illustrates the T-effect regression: 
 
𝒀𝒊 =  𝜷𝟎 + 𝜷𝟏𝑻𝒚𝒑𝒆 𝟏 𝑫𝒊𝒂𝒃𝒆𝒕𝒆𝒔𝒊 + 𝜷𝟐𝑨𝒈𝒆𝒊 + 𝜷𝟑𝑨𝒈𝒆
𝟐
𝒊
+ 𝜷𝟒𝑵𝒐𝒏 𝑾𝒉𝒊𝒕𝒆𝒊 +
 𝜷𝟓𝜮 𝑹𝒆𝒈𝒊𝒐𝒏 𝑫𝒖𝒎𝒎𝒊𝒆𝒔𝒊 + 𝜷𝟔𝑪𝒂𝒏𝒄𝒆𝒓𝒊 + 𝜷𝟕𝑨𝒓𝒕𝒉𝒓𝒊𝒕𝒊𝒔𝒊 + 𝜷𝟖𝑭𝒆𝒎𝒂𝒍𝒆𝒊 +
 𝜷𝟗𝜮𝑴𝒂𝒓𝒕𝒊𝒕𝒂𝒍 𝑺𝒕𝒂𝒕𝒖𝒔 𝑫𝒖𝒎𝒎𝒊𝒆𝒔𝒊 + 𝜷𝟏𝟎𝜮𝑬𝒅𝒖𝒄𝒂𝒕𝒊𝒐𝒏 𝑫𝒖𝒎𝒎𝒊𝒆𝒔𝒊 + 𝜷𝟏𝟏𝜮𝒀𝒆𝒂𝒓 𝑫𝒖𝒎𝒎𝒊𝒆𝒔𝒊 + 𝜺𝒊  
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 A second method for balancing, the entropy balance method referenced in 
“Entropy Balancing for Causal Effects: A Multivariate Reweighting Method to Produce 
Balanced Samples in Observational Studies” was employed (Hainmueller, 2012). 
Entropy balance allows one to reweight a dataset based on a maximum entropy weighing 
scheme that assigns weight to individual data units so the covariate distribution in the 
reweighted dataset satisfies a set of moment conditions. This method also helps to 
balance covariate distributions in studies with binary treatments where the control group 
data can be reweighted to match the covariate moments in the treatment group. Instead of 
just selecting a control group with propensity score matching, I was able to match on the 
mean, standard deviation and skewness for the continuous independent variables (age and 
age squared).  For the dummy variables I used to balance, when the command matches on 
the first moment, mean, the other two moments, standard deviation and skewness, are 
necessarily matched. This creates a synthetic control group that matches the treatment 
group on the treatment variables for all three moment conditions—mean, standard 
deviation and skewness for the specified covariates. It thereby eliminated both behavioral 
and environmental effects of T1D. The controls are the same as the OLS ones, and so the 
values I obtained were similar. The regression equation here is the same since I utilized 
the same selection criteria; 
 
𝒀𝒊 =  𝜷𝟎 + 𝜷𝟏𝑻𝒚𝒑𝒆 𝟏 𝑫𝒊𝒂𝒃𝒆𝒕𝒆𝒔𝒊 + 𝜷𝟐𝑨𝒈𝒆𝒊 + 𝜷𝟑𝑨𝒈𝒆
𝟐
𝒊
+ 𝜷𝟒𝑵𝒐𝒏 𝑾𝒉𝒊𝒕𝒆𝒊 +
 𝜷𝟓𝜮 𝑹𝒆𝒈𝒊𝒐𝒏 𝑫𝒖𝒎𝒎𝒊𝒆𝒔𝒊 + 𝜷𝟔𝑪𝒂𝒏𝒄𝒆𝒓𝒊 + 𝜷𝟕𝑨𝒓𝒕𝒉𝒓𝒊𝒕𝒊𝒔𝒊 + 𝜷𝟖𝑭𝒆𝒎𝒂𝒍𝒆𝒊 +
 𝜷𝟗𝜮𝑴𝒂𝒓𝒕𝒊𝒕𝒂𝒍 𝑺𝒕𝒂𝒕𝒖𝒔 𝑫𝒖𝒎𝒎𝒊𝒆𝒔𝒊 + 𝜷𝟏𝟎𝜮𝑬𝒅𝒖𝒄𝒂𝒕𝒊𝒐𝒏 𝑫𝒖𝒎𝒎𝒊𝒆𝒔𝒊 + 𝜷𝟏𝟏𝜮𝒀𝒆𝒂𝒓 𝑫𝒖𝒎𝒎𝒊𝒆𝒔𝒊 + 𝜺𝒊  
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V. RESULTS 
1.  EMPLOYMENT 
Based on the OLS regression as seen in Table 2, it would appear that having T1D 
has a negative impact on the likelihood of being employed, they are 11.5% less likely to 
be employed. This could be explained by those with T1D self-selecting out of the job 
market due to their inability to work. Alternatively, it is possible that employers would 
rather not hire those with T1D because of the high cost of medical care the employer 
might incur from paying for insurance.  
In terms of demographic factors, it appears that non-whites are 3.8% less likely to 
be employed. Being female shows that you are 15% less likely to be employed. People 
with an education less than high school are 13% less likely to be employed while their 
college counterparts are 10% more likely to be employed. There seems to be a strong 
correlation between marital status and employment. Based on the OLS regression, 
widowed people are 7% less likely to be employed, while divorcees are 3% likely to be 
employed. Finally, we see that folks that were never married are 2% less likely to be 
employed. Lastly, In the year dummy, we can see how the employment rate increases, we 
see that people were 1 percentage point likely to be employed, likely due to the effect of 
the recovery from the recession in 2009. 
Based on the t-effect regression in Table 2, we can see the average treatment 
effect on those without T1D, having T1D means you are 16% less likely to be employed. 
This is in comparison to the average treatment effects on the treated also from Table 2, 
showing that those with T1D are 16% less likely to be employed. The entropy balance 
results from Table 6 were very similar to the OLS results, showing that those with T1D 
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are 11.5% points less likely to be employed. Nonwhites are also shown to be 9 
percentage points less likely to be employed. Having cancer and arthritis reduces your 
chance to employed by 9 percentage points and 22 percentage points respectively. Being 
female reduces your chance of being employed by 17 percentage points while having less 
than a high school degree reduces employment by 13 percentage points which seems 
surprisingly low compared to being female. Figure 1 shows the effects of age on 
employment opportunities for T1Ds and nondiabetics—as T1D’s grow older, their 
employability goes down. In those without T1D, however, employability remains the 
same.  
 
2. SICK DAYS 
Based on the OLS regression in Table 3, those with T1D are 28 percentage points 
more likely to take sick days. This result is expected based on the employment regression 
showing that those with T1D are less likely to be employed; this may be a result of T1D’s 
using too many sick days. Additionally, with a unit increase in age, you take 18 
percentage points more sick days—this makes sense as the older people get the more 
likely the chance of their health failing and this leads to the use of more sick days. As 
expected, age squared has a negative correlation. 
Non-whites were found to take less sick days than their white counterparts. Table 
3 shows that non-whites take 3% points less sick days, and as mentioned earlier, this 
could be due to the fact that the field they are working in do not have as many sick day 
benefits as compared to their white counterparts. Lastly, there appears to be strong 
positive coefficients for the cancer and arthritis diagnosis, seemingly larger than T1D. 
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Study results show that cancer patients take 35 percentage points more sick days, while 
those with arthritis take 43 percentage points more sick days than their healthy 
counterparts. Women seem to take more sick days than males, with results showing they 
take 21% more sick days, a result that is consistent with current literature. Divorcees are 
shown to take 11 percentage points more sick days as opposed to their married 
counterparts. People with less than high school take 13 percentage points less sick days 
and this could be explained as not having access to the sick days in their possible field of 
employment. 
In the t-effect regression showing the average treatment effect from Table 3, we 
can see that those with T1D take 18 percentage points more sick days, while the average 
treatment effect on the treated in Table 3 shows that T1Ds take 46% points more sick 
days. In the year 2013 we see that people took 6 percentage points more sick days, while 
in 2015 they took 19 percentage points more sick days. 
 Once again the entropy balance result from Table 3 shows that those with T1D 
take 29 percentage points more sick days than their nondiabetic counterparts. People with 
cancer took 36 percentage points more sick days while people with arthritis took 32 
percentage points more sick days which is to be expected. Unexpectedly people took 34 
percentage points more sick days in 2015. Figure 2 shows that with age, those with T1Ds 
take exceedingly more sick days than their nondiabetic counterparts who are predicted to 
take even fewer sick days as they get older. 
3. INCOME 
Table 4 shows no statistically significant impact on the wage of those T1D in 
comparison to the control group, which is quite surprising, as the expectation was to find 
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that T1Ds would be more risk averse at changing jobs because of the worry that the 
possible new manager could be less agreeable to taking so many sick days. The fear of 
losing a person with T1D from the work force could also have been a possible reason for 
the supposed belief in lower income for those with T1D. Age, on the other hand, shows a 
positive impact on wage. This is an expected outcome, as with increasing age comes an 
increase in employment stability one shows in their position, leading to expected growth 
and higher income. Age squared acts as expected, showing the negative effect. 
Nonwhites are shown to earn 3.8 percentage points less than their white counterparts. 
People with arthritis are seen to earn 4 percentage point less than their non-arthritis 
counterparts. Being female is correlated with earning 27 percentage points less than men, 
lining up with general consensus that women earn 75 cents to the dollar of most men. 
Widowed people earn 11.7 percentage points less than married people, while separated 
and never married people earn 16 percentage points and 14 percentage points less, 
respectively. People with less than a high school degree earn 40 percentage points less, 
while college goers earn 59 percentage points more than their counterparts with high 
school degrees as seen in other literature. We see that wage has an uptick as the years go 
by, this was explained earlier as the effect of the recovery from the recession.  
Finally, we see in the entropy balancing regression from Table 4, no statistically 
significant effect to wages for people with T1D. We do see as expected a 11 percentage 
point increase to wage with one age unit increase while we see an inverse effect with age 
squared. Females earn 30 percentage points lower as seen with other regressions and 
literature. Divorcees earn 30 percentage points less than their married counterparts. 
People with less than high school degrees earn 39 percentage points less while the people 
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with a college degree earn 60 percentage points higher than people with a high school 
degree, which is expected according to literature and other regressions. We also see that 
in the year 2013 and 2015 we get a 20 and 22 percentage point increase respectively. 
Figure 3 shows the difference in income between those with T1D and those without T1D. 
It shows that people without T1D get more income over time but as stated earlier results 
were not statistically significant. 
 
VI. CONCLUSION  
 Since T1D is a disease that is not-predictable, it is an effective example for 
showing the direct effects of poor health on employability. It is normally quite hard to 
isolate the economic impact of poor health alone due to the fact that most diseases have 
an environmental, genetic or nutritional etiology. This is not the case for those with T1D, 
demonstrating the severity of economic consequences that may result from such non-
predictable chronic illnesses.  
Results from this study suggest that having T1D does, in fact, negatively affect 
labor force participation in the US. Analysis of MEPS data shows that there is an overall 
decrease in employability as defined by a lower rate of employment and an increase in 
the number of used sick days. We did not, however, see a statistically significant 
correlation between having T1D and income level; we therefore cannot conclude that 
having T1D would affect a person’s income level. Treatment for T1D can be both time 
consuming and costly. Additionally, poorly managed T1D can lead to further 
complications including neuropathy, retinopathy, cardiovascular disease, hypoglycemia 
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and hyperglycemia. These disease-related complications would in turn lead to a further 
increase in use of sick days and potentially exclusion from the labor market.  
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TABLES 
 
 
Table 1 Summary Statistics   
 (1) (2) 
 Diabetics Non Diabetics 
 (SD) (SD) 
Employed 0.6658 0.7842 
 (0.4558) (0.3881) 
 
Sick days 4.4646 2.8265 
 (10.0781) (8.7888) 
 
Log of Sick Days 0.9119 0.5759 
 (1.1130) (0.9542) 
 
Wage 23211.7213 30740.4682 
 (30264.1850) (32982.5301) 
 
Log of Wage  7.1859 8.3875 
 (4.5244) (3.9629) 
 
Age 36.3115 37.2295 
 (7.4255) (7.5536) 
 
Nonwhite 0.2623 0.2968 
 (0.4411) (0.4568) 
 
Female 0.5628 0.5334 
 (0.4974) (0.4989) 
 
Cancer 0.0929 0.0325 
 (0.2911) (0.1773) 
 
Arthritis 
 
 
0.1585 
(0.3662) 
 
0.1176 
(0.3221) 
Married (0.4372) (0.5362) 
 (0.4974) (0.4987) 
 
Widowed 0.0000 0.0070 
 (0.0000) (0.0831) 
 
Divorced 0.1530 0.1003 
 (0.3610) (0.3004) 
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Separated 0.0273 0.0354 
 (0.1635) (0.1847) 
 
Never Married 0.3825 0.3211 
 (0.4873) (0.4669) 
 
Less than HS 0.1597 0.1731 
 (0.3676) (0.3784) 
 
High School Degree 0.6389 0.5602 
 (0.4820) (0.4964) 
 
College Degree 0.2014 
(0.4024) 
0.2667 
(0.4422) 
 
Standard deviation in parentheses 
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Table 2 Employment Regressions 
 (1) (2) (3) (4) (5) 
 OLS PS Logit PS ATE PS ATT Entropy 
Balance 
      
Type 1 Diabetes -0.115**  -0.166*** -0.163*** -0.115*** 
 (0.0358)  (0.0461) (0.0347) (0.0325) 
      
Age 0.00436 0.0489   0.00250 
 (0.00295) (0.126)   (0.0241) 
      
Age squared -0.0000428 0.000908   0.0000606 
 (0.0000391) (0.00169)   (0.000319) 
      
Nonwhite -0.0385*** -0.276   -0.0958** 
 (0.00441) (0.198)   (0.0369) 
      
      
Midwest 0.0397*** 0.105   -0.0852 
 (0.00660) (0.297)   (0.0515) 
      
South 0.0148* 0.249   -0.163*** 
 (0.00598) (0.260)   (0.0443) 
      
West 0.0141* -
0.000562 
  -0.0678 
 (0.00621) (0.281)   (0.0455) 
      
Cancer -0.0400** 1.379***   0.0924* 
 (0.0123) (0.270)   (0.0462) 
      
Arthritis -0.137*** 0.275   -0.224*** 
 (0.00709) (0.241)   (0.0480) 
      
Female -0.151*** -0.0193   -0.174*** 
 (0.00387) (0.172)   (0.0349) 
      
Widowed -0.0781** 0   -0.0458 
 (0.0291) (.)   (0.0450) 
      
Divorced 0.0393*** 0.559*   0.0571 
 (0.00656) (0.261)   (0.0527) 
      
Separated -0.000886 0.150   -0.0934 
 (0.0113) (0.472)   (0.0917) 
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Never Married -0.0256*** 0.492*   -0.0591 
 (0.00471) (0.200)   (0.0363) 
      
Less than HS -0.132*** -0.172   -0.138** 
 (0.00608) (0.237)   (0.0479) 
      
College Degree 0.101*** -0.304   0.0355 
 (0.00406) (0.216)   (0.0411) 
      
year=2012 -0.0109 0.0414   0.0472 
 (0.00681) (0.284)   (0.0567) 
      
year=2013 -0.00111 -0.591   -0.0931 
 (0.00680) (0.336)   (0.0666) 
      
year=2014 0.00732 0.147   0.0199 
 (0.00688) (0.284)   (0.0565) 
      
year=2015 0.0191** 0.0226   0.0830 
 (0.00602) (0.258)   (0.0501) 
      
Constant 0.774*** -6.330**   1.014* 
 (0.0548) (2.318)   (0.451) 
Observations 36549 36312 36312 36312 36549 
Standard errors in parentheses 
* p < 0.05, ** p < 0.01, *** p < 0.001 OLS (Ordinary Least Squared) PS ATE (Propensity score Average 
Treatment Effects) PS ATT (Propensity score Average Treatment Effects on the Treated) 
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Table 3 Sick Days Regressions 
 (1) (2) (3) (4) (5) 
 OLS PS Logit PS ATE PS ATT Entropy 
Balance 
      
Type 1 Diabetes 0.280*  0.182 0.465*** 0.292** 
 (0.110)  (0.0978) (0.104) (0.108) 
      
Age 0.0183* 0.0489   0.0291 
 (0.00819) (0.126)   (0.0616) 
      
Age squared 0.000308** -0.000908   -0.000481 
 (0.000109) (0.00169)   (0.000829) 
      
Nonwhite -0.0355** -0.276   0.117 
 (0.0124) (0.198)   (0.112) 
      
Midwest 0.0413* 0.105   -0.0288 
 (0.0192) (0.297)   (0.162) 
      
South -0.0439** 0.249   -0.0467 
 (0.0166) (0.260)   (0.160) 
      
West -
0.0000388 
-0.000562   0.0772 
 (0.0174) (0.281)   (0.163) 
      
Cancer 0.355*** 1.379***   0.364* 
 (0.0405) (0.270)   (0.168) 
      
Arthritis 0.436*** 0.275   0.324* 
 (0.0228) (0.241)   (0.138) 
      
Female 0.215*** -0.0193   0.159 
 (0.0110) (0.172)   (0.0909) 
      
Widowed 0.0935 0   0.185 
 (0.0826) (.)   (0.131) 
      
Divorced 0.114*** 0.559*   0.219 
 (0.0201) (0.261)   (0.172) 
      
Separated 0.0543 0.150   0.211 
 (0.0313) (0.472)   (0.228) 
      
Never Married 0.0206 0.492*   0.0769 
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 (0.0131) (0.200)   (0.109) 
      
Less than HS -0.131*** -0.172   0.0604 
 (0.0154) (0.237)   (0.170) 
      
College Degree 0.0238 -0.304   0.134 
 (0.0125) (0.216)   (0.119) 
      
year=2012 -0.0267 0.0414   -0.276 
 (0.0179) (0.284)   (0.157) 
      
year=2013 0.0628*** -0.591   0.00741 
 (0.0184) (0.336)   (0.172) 
      
year=2014 0.0340 0.147   0.0106 
 (0.0185) (0.284)   (0.171) 
      
year=2015 0.193*** 0.0226   0.341* 
 (0.0170) (0.258)   (0.166) 
      
Constant 0.138 -6.330**   -0.0938 
 (0.152) (2.318)   (1.124) 
Observations 30118 36312 29949 29949 30118 
Standard errors in parentheses 
* p < 0.05, ** p < 0.01, *** p < 0.001 OLS (Ordinary Least Squared) PS ATE (Propensity score Average 
Treatment Effects) PS ATT (Propensity score Average Treatment Effects on the Treated) 
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Table 4 Wage Regressions 
 (1) (2) (3) (4) (5) 
 OLS PS Logit PS ATE PS ATT Entropy 
Balance 
      
Type 1 Diabetes -1.080**  -1.489*** -1.517*** -1.079** 
 (0.360)  (0.430) (0.395) (0.329) 
      
Age 0.0650* 0.0489   -0.125 
 (0.0296) (0.126)   (0.245) 
      
Age squared -0.000698 -0.000908   0.00133 
 (0.000392) (0.00169)   (0.00326) 
      
Nonwhite -0.361*** -0.276   -0.437 
 (0.0444) (0.198)   (0.367) 
      
Midwest 0.337*** 0.105   -0.696 
 (0.0669) (0.297)   (0.508) 
      
South 0.109 0.249   -1.407** 
 (0.0605) (0.260)   (0.445) 
      
West 0.140* -0.000562   -0.374 
 (0.0631) (0.281)   (0.451) 
      
Cancer -0.436*** 1.379***   0.801 
 (0.126) (0.270)   (0.444) 
      
Arthritis -1.324*** 0.275   -2.181*** 
 (0.0721) (0.241)   (0.529) 
      
Female -1.673*** -0.0193   -2.020*** 
 (0.0390) (0.172)   (0.358) 
      
Widowed -0.598* 0   -0.188 
 (0.290) (.)   (0.445) 
      
Divorced 0.505*** 0.559*   0.677 
 (0.0648) (0.261)   (0.511) 
      
Separated 0.118 0.150   -0.859 
 (0.111) (0.472)   (0.920) 
      
Never Married -0.268*** 0.492*   -0.480 
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 (0.0471) (0.200)   (0.371) 
      
Less than HS -1.550*** -0.172   -1.292** 
 (0.0602) (0.237)   (0.499) 
      
College Degree 1.422*** -0.304   0.478 
 (0.0418) (0.216)   (0.437) 
      
year=2012 -0.0988 0.0414   0.00981 
 (0.0684) (0.284)   (0.529) 
      
year=2013 0.0124 -0.591   -1.381 
 (0.0684) (0.336)   (0.728) 
      
year=2014 0.0798 0.147   -0.127 
 (0.0692) (0.284)   (0.513) 
      
year=2015 0.191** 0.0226   0.425 
 (0.0605) (0.258)   (0.453) 
      
Constant 7.905*** -6.330**   13.52** 
 (0.549) (2.318)   (4.571) 
Observations 36549 36312 36312 36312 36549 
Standard errors in parentheses 
* p < 0.05, ** p < 0.01, *** p < 0.001 OLS (Ordinary Least Squared) PS ATE (Propensity score Average 
Treatment Effects) PS ATT (Propensity score Average Treatment Effects on the Treated) 
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FIGURES 
Figure 1| Employment Rate Predictive Margins in Those With and Without T1D  
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Figure 2| Sick Days Predictive Margins in Those With and Without T1D 
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Figure 3| Wage Income Predictive Margins in Those With and Without T1D 
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